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model spending. We report adjusted relative risks (adjusted_RR) with 95% confi-
dence intervals (CIs) formultivariable logistic regressions and adjusted coefficients
with standard errors and p values for results from OLS models, controlling for
covariates. RESULTS: Inmultivariablemodels, COPDmaintenancemedication dis-
continuation increased hospitalization risk (RR 1.08, 95%CI 1.06, 1.10), while high
MPR reduced hospitalization risk (RR  0.93, 95% CI 0.91, 0.95) compared to low
MPR. Medication discontinuation also increased total spending by $2350 (p 
0.001), driven largely by Part A spending ($4039; p 0.001) and offset by Part D drug
spending reductions (-$1,833; p 0.001). High adherence significantly reduced total
spending by $4273 (p 0.001),whilemoderate adherence reduced spending by $936
(p  0.05) relative to poor adherence. CONCLUSIONS: Findings highlight the im-
portance of adhering to prescribed pharmacologic regimens of COPDmaintenance
medication in reducing hospitalizations and associated costs.
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OBJECTIVES: Isoniazid ishighly effectiveandwidelyused forTBpreventionand treat-
ment; however itmust be used consistently for 6 to 9months to treat latent TB,which
is usually asymptomatic. The combination of long-term therapy and lack of symp-
toms results in high risk for non-adherence. The cost of subsequent treatment for
patients with isoniazid resistance is estimated at $1million per reactivation case pre-
vented. These data highlight the need for more information about adherence with
isoniazid in patients with latent TB. The specific aim of this study was to document
adherence patterns in patients with latent TB and examine associations with patient
characteristics. We also examined patient’s attitudes toward intentional nonadher-
ence in relation tomedical doubts, lack of social support, andmedication side effects
by using the Temptation to Skip Therapy (TEST) scale. METHODS: Questionnaires
were completed at baseline by 211 isoniazid treated patients (aged 18-66) at the Rhode
IslandTuberculosis Clinic. Adherencewas subsequentlymeasured at 6 and 9months.
The average score was computed for each TEST subscale and the association with
each subscale and the Morisky Medication Adherence Scale (MAS) was examined.
RESULTS: Adherence to INH therapy was 45% (by MAS). Latent TB patients scored
highest on theSideEffect (Mean1.62) and lowest on theTESTMedicalDoubt subscale
(Mean  1.47). Non-Whites exhibited higher mean scores on the Medical Doubt sub-
scale indicating uncertainty toward the need for therapy. Patients with higher scores
on the Medical Doubt and Side Effect subscales had higher non-adherence levels.
CONCLUSIONS: Latent TB patients exhibited low adherence with isoniazid therapy.
Fear of side effects and doubts about the need for medication were related to discon-
tinuation of therapy. Better understanding of attitudes toward isoniazid therapymay
be beneficial for improving adherence, and reducing costs associated with isoniazid
treatment.
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IMPACT OF MORBIDITY, PSYCHOLOGICAL DISTRESS AND LUNG FUNCTION ON
PHYSICAL FUNCTIONING IN A RETIRED POPULATION
Roberts M, Mapel D
LCF Research, Albuquerque, NM, USA
OBJECTIVES: Physical functioning scales have been used to assess risk for disabil-
ity, propensity for healthcare utilization, and impact on quality of life (QOL) scores.
Understanding related factors in a nationally representative older population is
important for designing effective physical functioning improvement programs,
potentially decreasing utilization and increasing QOL.METHODS: To measure im-
pact of demographics, morbidities, psychological distress and lung function on
physical functioning among the retired, a retrospective main effects analysis of
data from the Health and Retirement Study (HRS) for subjects surveyed in 2006 and
2008 was performed on a sample of 13,129 patients aged 50 years (M  66.14;
45.9% male) with lung function measurement (peak expiratory flow (PEF)), and
psychological distress (symptoms of anxiety and depression) assessment (8 ques-
tion Center for Epidemiologic Studies Depression Scale (CES-D8)), and self-reported
confirmation of morbidity diagnoses. Morbidities were diabetes (19.4%), chronic
obstructive pulmonary disease (COPD) (9.8%), heart disease (23.6%), cancer (13.7%),
and stroke (6.0%). RESULTS: In a weighted multiple regression model of physical
function difficulty score, 49% of the variance was explained by analyzed variables.
In a weighted logistic regression model for difficulties with 4 physical functions
(max12), adjusted for age and race, odds were significantly higher for subjects
reporting morbidities of frequent pain (odds ratio range (ORR) 6.0-7.7), COPD (ORR
2.4-3.4), stroke (ORR 2.0-2.8), heart disease (ORR 1.6-1.9), or diabetes (ORR 1.7-2.2). In
addition, greater risk for physical function difficulties was associated with psycho-
logical distress (ORR 2.2-3.0) and low PEF scores (80% of predicted, ORR 1.7-2.1).
Among retirees with COPD, 59.3% had low PEF scores compared to 23.7% without;
34.8% had psychological distress compared to 19.6% without. CONCLUSIONS: The
secondary database of longitudinal data from the HRS offers valuable information
for understanding factors associated with functional limitations. Mental health
and lung functioning are potential areas for focusing improvement efforts.
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BACKGROUND: Patients with COPD have demonstrated poor adherence and persis-
tence with inhaledmaintenancemedications, suggesting low satisfaction with exist-
ing therapies. An understanding of the factors driving treatment satisfaction from the
patient perspective is necessary to develop or modify therapies to address patients’
concerns. OBJECTIVES: To examine factors influencing patients’ satisfaction with
COPD maintenance medications. METHODS: Fifty-two one-on-one semi-structured
telephone interviewswere conductedwithCOPDpatients to gather informationabout
attributes that influence satisfaction with COPD maintenance medication and deliv-
ery devices. Participantswere selected from two sources: patientswho recently exited
one of two trialswith aclidiniumbromide via theGenuair™ inhaler(n32) or non-trial
patients recruited from clinics who recently received treatment with tiotropium bro-
mide via the HandiHaler™(n20). A coding scheme for categorizing responses was
developed and interview transcripts were analyzed using qualitative software.
RESULTS: Focus group participants had amean age of 66.5 years; were 51.9% female;
andhadadiagnosis ofmoderate (GOLD II) to severe (GOLD III) COPD. Four components
of patients’ satisfaction were identified: ease of use/convenience, efficacy, onset of
action, and side effects. Regarding ease of use/convenience, patients most frequently
cited the importance of device portability (31%), device simplicity (27%), and whether
the device indicated that a dose had been received (25%). For efficacy, patients most
frequently mentioned whether the product made them feel that their airways were
open and they could catch their breath (42%), that the medication kept symptoms
from worsening (33%), and that the medication improved ambulatory ability (29%).
Nearly half of patients (46%) noted onset of action as important. Finally, thirty-five
percent of patients noted that side effects affected their satisfaction with treatment.
CONCLUSIONS: Ease of use/convenience, efficacy, onset of action, and side effects
drive patients’ satisfactionwith inhaled COPDmaintenancemedications. COPDmed-
ications and delivery devices that address these factors may improve patient adher-
ence and persistence.
PRS26
RELIABILITY AND VALIDITY OF THE EXACT-RESPIRATORY SYMPTOMS (E-RS)
SCORE TO QUANTIFY THE SEVERITY OF RESPIRATORY SYMPTOMS OF COPD
Sexton CC1, Leidy N1, Notte S1, Jones P2, Monz BU3, Nelsen L4, Ramachandran S5,
Sethi S6
1United BioSource Corporation, Bethesda, MD, USA, 2St. George’s, University of London, London,
UK, 3Boehringer Ingelheim GmbH, Ingelheim, Germany, 4Merck, Whitehouse Station, NJ, USA,
5AstraZeneca, Wilmington, DE, USA, 6University at Buffalo, SUNY, Buffalo, NY, USA
OBJECTIVES: Although respiratory symptoms are a defining feature of COPD, a
standardized method for assessing their day-to-day severity suitable for testing
treatment effects in clinical trials has not been established. This study examined
the reliability and validity of the E-RS (EXACT-Respiratory Symptoms), a respira-
tory symptom score derived from the 11 respiratory items of the 14-item EXACT, a
daily diary assessing exacerbations of COPD. METHODS: Content validity was as-
sessed through analyses of qualitative data from 84 patients with COPD, including
secondary analyses of data collected during EXACT development (n63) and data
from four new focus groups with patients without recent history of exacerbation
(n21). Quantitative properties were tested through secondary analyses of data
from 188 stable COPD patients gathered over 7 days during the first EXACT valida-
tion study. RESULTS: Qualitative: Sample mean (SD) age65(10), 44% male, mean
FEV11.2(0.4) L. Patient descriptions of respiratory symptoms during stable disease
were consistent with the E-RS content, wording, and structure. Quantitative: Sam-
plemean (SD) age66 (10), 50%male,mean FEV11.2(0.5) L. Factor analysis showed
three subscales: RS-Breathlessness (5 items), RS-Cough & Sputum (3 items) and
RS-Chest (3 items). For RS-Total and subscale scores, respectively: Reliability, in-
ternal consistency (alpha) 0.88 0.86, 0.73, 0.80; test-retest (ICC) Day 1 to 7 (n171)
0.73; 0.71; 0.69; 0.62. Validity: Correlations (Spearman’s) with St. George Respira-
tory Questionnaire – COPD (SGRQ-C) 0.75; 0.69, 0.58, 0.52, modified Medical Re-
search Council dyspnea scale (mMRC)0.33; 0.38, 0.24, 0.16, and rescuemedication
use 0.32; 0.34, 0.26, 0.17 (p0.05 to 0.0001). CONCLUSIONS: Results suggest the
E-RS is a valid and reliablemethod for evaluating severity of respiratory symptoms
in COPD; the daily diary structure permits assessment of day-to-day variability and
severity over time. Further research is needed to evaluate performance over longer
assessment periods and in response to treatment, and to refine score interpreta-
tion.
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OBJECTIVES: There is currently no validated tool to evaluate nighttime symptoms
in patients with COPD. The purpose of this study was to develop and test a patient
reported outcome (PRO) self-administered questionnaire for evaluating COPD
symptoms experienced during the night.METHODS: A review of the literature and
interviews with six clinical experts informed the development of a framework for
exploring patients’ experience with nighttime symptoms of COPD. Four focus
groups were conducted with twenty-seven subjects who experienced COPD symp-
toms at night or in the earlymorning. Trained interviewers used a semi-structured
interview guide, startingwith open ended questions. Grounded theorywas applied
using qualitative analysis software to identify key concepts and determine concept
saturation. A conceptual framework was developed to depict patients’ experience
with COPD symptoms at night. Items and response options were generated based
on the qualitative data. Subsequently, one-on-one cognitive debriefing interviews
were conducted with 10 COPD patients to assess item readability, comprehensive-
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ness, and content validity. Items were edited based on feedback from the patients.
RESULTS: Focus group participants had a mean age of 68.1 years; were 51.9% fe-
male; and had a range of COPD severity levels (GOLD Stages): 7.4% GOLD I (mild),
55.6% GOLD II (moderate), 14.8% GOLD III (severe), 22.2% GOLD IV (very severe). A
sizable majority (N24; 88.8%) experienced COPD symptoms at night. Focus group
data supported saturation of concepts to evaluate how patients experience COPD
symptoms at night. Items were generated for the Nighttime Symptoms of COPD
Instrument using patient terminology. Subsequent cognitive debriefing with pa-
tients demonstrated that the itemswere understandable, relevant, and interpreted
as intended. CONCLUSIONS: The Nighttime Symptoms of COPD Instrument is a
PRO instrument developed to evaluate nighttime symptoms of COPD with docu-
mented evidence of content validity. Psychometric testing is planned in order to
evaluate the instrument’s measurement properties.
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ABSENTEEISM IN CHILDREN: USING DATA FROM THE NATIONAL HEALTH
INTERVIEW SURVEY (NHIS)
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OBJECTIVES: To evaluate the effects of physician-provided asthma education on
absenteeism due to pediatric asthma.METHODS: This study was conducted using
data from the 2008National Health InterviewSurvey, Sample ChildData Set (NHIS).
Children were included in the study if they were diagnosed with asthma, reported
to have asthma at the time of the survey, had an asthma attack in the past 12
months and were excluded if there was no data available on absenteeism. A com-
posite score (0-6) was assigned for the comprehensiveness of the physician-pro-
vided education. The dependent variable was the number of school/work days
missed due to asthma over the last 12 months. The independent variables were
gender, age, race, ER visit, prescription inhaler use and extent of physician-pro-
vided education. Descriptive statistics were used to describe the population and
the amount of physician-provided education. Logistic regression was used to eval-
uate the effects of physician-provided education on absenteeism over 12 months.
SASv.9.2 was utilized for analyses. RESULTS: A total of 427 children were included
in the final sample from amongst the 1,225 children suffering from asthma. The
majority were White (54.8%), and males (59.3%). The median age was 9 years,
median number of school days missed was 2 (mean4.3, SD7.9) and mean com-
posite score was 3.28. Childrenwhose parents received a higher than average com-
prehensive education (OR2.18;CI1.12-4.24) and used a rescue inhaler (OR2.27;
CI1.44-3.60) were more likely to have a lower number of missed school days than
those with less comprehensive education and not using a rescue inhaler. Lower
absenteeism was reported among children who had an ER visit due to asthma
(p0.0001). CONCLUSIONS: When comprehensive in nature, asthma education
provided by physicianswas found to have a positive impact on absenteeismamong
this population, suggesting that education is an integral component of asthma
management in addition to drug therapy.
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OBJECTIVES: To evaluate knowledge, awareness and perception of TB among stu-
dents living in university hostels.METHODS:A cross sectional studywas designed.
A total of 502 students (200 from males and 302 from females) living in hostels of
The Islamia University Bahawalpur, Pakistan were selected purposively. A ques-
tionnaire about knowledge, awareness and perception of tuberculoses was con-
structed, content validated and used for data collection. Descriptive analysis was
done by using SPSS 16. RESULTS: Sixty (30%) of males and 215 (71.2%) of females
have heard about TB. Less than half (n99) of males and (n192) of females stated
thatmalnutrition is onemajor factor for occurrence of TB. 44.5%ofmales and 68.9%
of females knew that persistent cough, low grade fever and weight loss are symp-
toms of tuberculosis. A total of 45% of males and 42.1% of female knew that TB
spreads by sneezing and coughing. Less than 75% of both respondents knew that
TB is curable but knowledge about TB vaccinationwas very poor (20%). Twomales
and one female reported that they are suffering from tuberculosis and no precau-
tionary measures have been taken by their roommates. 70.3% of males and 23.1%
of females were sharing utensils and other items with their room mates. Majority
of students (80.5%males, 89.07% females) stated that quality of life in the hostels is
poor as it is over crowded. Almost all of male and female students reported that
theywere not screened for tuberculosis and other communicable illness before and
after registration in university. CONCLUSIONS: This study demonstrated a strong
need of health educational programs for general public especially at schools, col-
leges and university levels. Students must be screened for communicable diseases
like tuberculosis before registration.
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OBJECTIVES:Our aimwas to evaluate the construct validity of generic and disease-
specific measures of health in chronic obstructive pulmonary disease (COPD) with
a specific focus on the relative ability of the measures to discriminate between
clinically defined stages of COPD.METHODS:We analyzed data collected from 120
patients with a diagnosis of COPD in a Veterans Affairs hospital. Patients self-
completed 2 genericmeasures (EQ-5D and SF-36), and the disease-specificmeasure
St. George’s Respiratory Questionnaire (SGRQ). Known groups comparisons for the
SGRQ, EQ-index, VAS, MCS-12, and PCS-12 scores were conducted by grouping
patients according to Global Obstructive Lung Disease (GOLD) stages based on
forced expiratory volume in one second (FEV1). Pearson’s correlation was used to
assess the associations between clinical and HRQL measurements. Relative effi-
ciency ratios (REs) were used to assess the statistical efficiency of each summary
score in discriminating among levels of clinical severity of COPD. RESULTS: Mean
PCS-12, EQ-VAS and SGRQ total scores significantly declined with stage of severity
(p 0.05). The SGRQ was more discriminative than EQ-5D and SF-36 in the severe
stages. The generic summary scores demonstrated trivial correlations with FEV1
(r0.2) whereas SGRQ showed amoderate correlation (r0.43). The SGRQ exhibited
a stronger correlation with Borg dyspnea score (r0.5) than the generic summary
scores. Using SGRQ as the reference, PCS-36, MCS-36, EQ index, EQ-VAS all had REs
of 1. CONCLUSIONS: The SGRQ demonstrated greater ability to discriminate
among different levels of severity stages of COPD and is more strongly correlated
with clinical measures of COPD than generic measures of health, an important
consideration when selecting measures in studying patients with COPD.
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DEVELOPMENT OF A QUESTIONNAIRE ASSESSING THE BURDEN OF PRURITUS
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OBJECTIVES: The severity of pruritus may be modest, but it may also be very
significant and cause considerable discomfort to the patient. In an difficult eco-
nomic context, the public health burden is increasingly often a legitimate concern
for health authorities. A tool designed to evaluate the burden needs to be made
available to health professionals in order to conduct an objective assessment. To
explore the handicap, in the largest sense, generated by pruritus (scratching or
itching) using a questionnaire to express the burden of the symptom on the daily
life of patients. METHODS: The questionnaire was developed following a strict
methodological process, involving a multidisciplinary team incorporating various
players (doctors, nurses, social workers) who are involved in the treatment of pa-
tients and caring for their families in order to guarantee its credibility and reliabil-
ity. A review of the literature and discussions with the children and their families
were conducted in order to identify the concepts related to the pathology.
RESULTS: Exploratory assessments showed that the concept of burden could be
structured around 2modules: frequency and severity for the firstmodule; daily life,
family and personal relationships, work and psychological impact for the second
module. Forty-two preliminary itemswere identified following a first discussion. A
first analysismanaged to reduce these items to 29 whilst conserving the 2modules
but making it easier to use the analysis. CONCLUSIONS: Whilst being a frequent
symptom, particularly dermatologically, the overall consequences of pruritus in
terms of public health are difficult to assess by clinical or quality of life aspects
alone as its impact can be multidimensional. Several existing questionnaires at-
tempt to assess one or other of these components; the BOSIP (Burden of Scratching,
Itching and Pruritus) questionnaire takes them all into consideration in order to
explain every angle of the handicap generated.
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HOSPITAL COST VERSUS MEDICARE PAYMENT FOR RESPIRATORY
INSUFFICIENCY, ARREST AND FAILURE
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OBJECTIVES: Respiratory insufficiency, failure and arrest (RIAF) are subjects of
contemporary healthcare policy discussions. AHRQ reports that RIAF are among
the top five conditions with the most rapidly increasing hospital costs for Medi-
care-covered stays in the US. CMS proposes adding Postoperative Respiratory Fail-
ure as a Patient Safety Indicator to the hospital inpatient quality reporting program.
While the cost of RIAF is known, it is unknown whether Medicare MS-DRG pay-
ments compensate hospitals adequately for these conditions. The objective of this
study is to compare hospital costs for patients with RIAF with MS-DRG payments
and to identify cost/payment discrepancies per case of RIAF. METHODS: We se-
lected all adult Medicare inpatient discharges from the Premier Perspective™ Da-
tabase (PPD) for CY2009. PPD is the largest hospital resource utilization and eco-
nomic database in the USA. RIAF were identified using ICD-9-CM codes. Of the top
ten MS-DRGs assigned to cases with RIAF diagnoses, we compared the mean total
hospitalization costs reported in the PPD with average MS-DRG payments (wage
index  1; geographic adjustment factor  1) for 2009. RESULTS: The top 10 MS-
DRGs assigned to RIAF diagnoses included those for respiratory system diseases,
septicemia, and heart failure. Five of the top ten MS-DRGs described major com-
plicating conditions; four described ventilator support. The top 10 MS-DRGs ac-
counted for 60% of all MS-DRGs assigned to RIAF. The average total hospitalization
cost reported by hospitals was $24,912 ($9,830-$75,670). The average Medicare pay-
ment for these 10 MS-DRGs was $19,167 ($7,448-$63,598). CONCLUSIONS: Hospital
providers risk an average loss of $5,745 ($2,121-$12,072) per case of RFIA. Consid-
ering the cost and the public policy focus on respiratory failure, better strategies for
the prevention of, monitoring for and management of RFIA in hospital patients
could lead to improved outcomes and substantial cost savings for hospitals.
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